Northwest Biotherapeutics Inc

Northwest Biotherapeutics Inc

NWBO

Get informed when a big investor buys or sells

+ Follow
Market Cap$312.24M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Northwest Biotherapeutics IncNorthwest Biotherapeutics Inc-6.2-120%--1.7
$-0.15

Current Fair Value

179.1% downside

Overvalued by 179.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$312.24 Million
Enterprise Value$374.44 Million
Dividend Yield$- (-)
Earnings per Share$-0.04
Beta-0.66
Outstanding Shares1,584,843,000

Return

Return on Equity119.87%ROE
Return on Assets-56.99%
Return on Invested Capital1814.00%

Valuation & Multiples

P/E Ratio-6.23P/E Ratio
PEG7.54PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.19Price to Book Ratio
Enterprise Value to Revenue250.13
Enterprise Value to EBIT-7.06
Enterprise Value to Net Income-9
Total Debt to Enterprise0.17
Debt to Equity-1.68Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 15, 2026
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Next Earnings Call

Expected Date
August 13, 2026
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.03%▲ 0.01%
Total Invested$83,294▲ 90.77%
Investors Holding6▲ 1.00%

ESG Score

No data

About Northwest Biotherapeutics Inc

CEO: Linda Powers